LAPTM4A interacts with hOCT2 and regulates its endocytotic recruitment

Cellular and Molecular Life Sciences

Volumn 68, Issue 24, 2011, Pages 4079-4090

  Grabner, A ^a   Brast, S ^a   Sucic, S ^b   Bierer, S ^a   Hirsch, B ^a   Pavenstadt H ^a   Sitte, H H ^b   Schlatter, E ^a   Ciarimboli, G ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Endocytosis; LAPTM4A; Organic cation transporter; Regulation; Trafficking

Indexed keywords

LAPTM4A PROTEIN; MEMBRANE PROTEIN; OCTAMER TRANSCRIPTION FACTOR 2; UNCLASSIFIED DRUG;

ARTICLE; BIOTINYLATION; CELL MEMBRANE; CELL TRANSPORT; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; KIDNEY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

BIOLOGICAL TRANSPORT; ENDOCYTOSIS; ENDOSOMES; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEK293 CELLS; HUMANS; KIDNEY TUBULES, PROXIMAL; LYSOSOMES; MEMBRANE TRANSPORT PROTEINS; ORGANIC CATION TRANSPORT PROTEINS; PROTEIN INTERACTION MAPPING; RNA, MESSENGER;

EID: 82255186488     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-011-0694-6     Document Type: Article

References (44)

1. Busch AE, Karbach U, Miska D, Gorboulev V, Akhoundova A, Volk C, Arndt P, Ulzheimer JC, Sonders MS, Baumann C, Waldegger S, Lang F, Koepsell H (1998) Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol 54:342-352 (Pubitemid 28368824)
2. Ogasawara M, Yamauchi K, Satoh Y, Yamaji R, Inui K, Jonker JW, Schinkel AH, Maeyama K (2006) Recent advances in molecular pharmacology of the histamine systems: organic cation transporters as a histamine transporter and histamine metabolism. J Pharmacol Sci 101:24-30 (Pubitemid 43765333)
3. Urakami Y, Kimura N, Okuda M, Inui K (2004) Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney. Pharm Res 21:976-981 (Pubitemid 38870147)
4. Barendt WM, Wright SH (2002) The human organic cation transporter (hOCT2) recognizes the degree of substrate ionization. J Biol Chem 277:22491-22496 (Pubitemid 34967222)
5. Kimura N, Okuda M, Inui K (2005) Metformin transport by renal basolateral organic cation transporter hOCT2. Pharm Res 22:255-259 (Pubitemid 40487209)
6. Yonezawa A, Masuda S, Yokoo S, Katsura T, Inui K (2006) Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family). J Pharmacol Exp Ther 319:879-886
7. Ciarimboli G, Ludwig T, Lang D, Pavenstadt H, Koepsell H, Piechota HJ, Haier J, Jaehde U, Zisowsky J, Schlatter E (2005) Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. Am J Pathol 167:1477-1484 (Pubitemid 41713303)
8. Busch AE, Quester S, Ulzheimer JC, Waldegger S, Gorboulev V, Arndt P, Lang F, Koepsell H (1996) Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1. J Biol Chem 271:32599-32604 (Pubitemid 27008679)
9. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, Baumann C, Lang F, Busch AE, Koepsell H (1997) Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 16:871-881 (Pubitemid 27332696)
10. Ciarimboli G, Schlatter E (2005) Regulation of organic cation transport. Pflugers Arch 449:423-441 (Pubitemid 40238877)
11. Ciarimboli G (2008) Organic cation transporters. Xenobiotica 38:936-971
12. Taubert D, Grimberg G, Stenzel W, Schomig E (2007) Identification of the endogenous key substrates of the human organic cation transporter OCT2 and their implication in function of dopaminergic neurons. PLoS One 2:e385
13. Urakami Y, Okuda M, Masuda S, Akazawa M, Saito H, Inui K (2001) Distinct characteristics of organic cation transporters, OCT1 and OCT2, in the basolateral membrane of renal tubules. Pharm Res 18:1528-1534 (Pubitemid 33022407)
14. Motohashi H, Sakurai Y, Saito H, Masuda S, Urakami Y, Goto M, Fukatsu A, Ogawa O, Inui KK (2002) Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J Am Soc Nephrol 13:866-874 (Pubitemid 34274082)
15. Urakami Y, Okuda M, Saito H, Inui K (2000) Hormonal regulation of organic cation transporter OCT2 expression in rat kidney. FEBS Lett 473:173-176 (Pubitemid 30254285)
16. Asaka J, Terada T, Okuda M, Katsura T, Inui K (2006) Androgen receptor is responsible for rat organic cation transporter 2 gene regulation but not for rOCT1 and rOCT3. Pharm Res 23:697-704
17. Cetinkaya I, Ciarimboli G, Yalcinkaya G, Mehrens T, Velic A, Hirsch JR, Gorboulev V, Koepsell H, Schlatter E (2003) Regulation of human organic cation transporter hOCT2 by PKA, PI3 K, and calmodulin-dependent kinases. Am J Physiol Renal Physiol 284:F293-F302 (Pubitemid 36114692)
18. Ciarimboli G, Struwe K, Arndt P, Gorboulev V, Koepsell H, Schlatter E, Hirsch JR (2004) Regulation of the human organic cation transporter hOCT1. J Cell Physiol 201:420-428 (Pubitemid 39456441)
19. Schlatter E, Mönnich V, Cetinkaya I, Mehrens T, Ciarimboli G, Hirsch JR, Popp C, Koepsell H (2002) The organic cation transporters rOCT1 and hOCT2 are inhibited by cGMP. J Membr Biol 189:237-244 (Pubitemid 36930160)
20. Mehrens T, Lelleck S, Cetinkaya I, Knollmann M, Hohage H, Gorboulev V, Boknik P, Koepsell H, Schlatter E (2000) The affinity of the organic cation transporter rOCT1 is increased by protein kinase C-dependent phosphorylation. J Am Soc Nephrol 11:1216-1224 (Pubitemid 30416217)
21. Soodvilai S, Chatsudthipong A, Chatsudthipong V (2007) Role of MAPK and PKA in regulation of rbOCT2-mediated renal organic cation transport. Am J Physiol Renal Physiol 293:F21-F27 (Pubitemid 47344997)
22. Wilde S, Schlatter E, Koepsell H, Edemir B, Reuter S, Pavenstadt H, Neugebauer U, Schroter R, Brast S, Ciarimboli G (2009) Calmodulin-associated post-translational regulation of rat organic cation transporter 2 in the kidney is gender dependent. Cell Mol Life Sci 66:1729-1740
23. Cabrita MA, Hobman TC, Hogue DL, King KM, Cass CE (1999) Mouse transporter protein, a membrane protein that regulates cellular multidrug resistance, is localized to lysosomes. Cancer Res 59:4890-4897 (Pubitemid 29472893)
24. Schmid JA, Scholze P, Kudlacek O, Freissmuth M, Singer EA, Sitte HH (2001) Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells. J Biol Chem 276:3805-3810
25. Bartholomaus I, Milan-Lobo L, Nicke A, Dutertre S, Hastrup H, Jha A, Gether U, Sitte HH, Betz H, Eulenburg V (2008) Glycine transporter dimers: evidence for occurrence in the plasma membrane. J Biol Chem 283:10978-10991
26. Hogue DL, Ellison MJ, Young JD, Cass CE (1996) Identification of a novel membrane transporter associated with intracellular membranes by phenotypic complementation in the yeast Saccharomyces cerevisiae. J Biol Chem 271:9801-9808 (Pubitemid 26137393)
27. Hogue DL, Nash C, Ling V, Hobman TC (2002) Lysosome-associated protein transmembrane 4 alpha (LAPTM4 alpha) requires two tandemly arranged tyrosine-based signals for sorting to lysosomes. Biochem J 365:721-730 (Pubitemid 34864454)
28. Maeda K, Horikoshi T, Nakashima E, Miyamoto Y, Mabuchi A, Ikegawa S (2005) MATN and LAPTM are parts of larger transcription units produced by intergenic splicing: intergenic splicing may be a common phenomenon. DNA Res 12:365-372
29. Hogue DL, Kerby L, Ling V (1999) A mammalian lysosomal membrane protein confers multidrug resistance upon expression in Saccharomyces cerevisiae. J Biol Chem 274:12877-12882
30. Cui M, Aras R, Christian WV, Rappold PM, Hatwar M, Panza J, Jackson-Lewis V, Javitch JA, Ballatori N, Przedborski S, Tieu K (2009) The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc Natl Acad Sci USA 106:8043-8048
31. Swanson KS, Vester BM, Apanavicius CJ, Kirby NA, Schook LB (2009) Implications of age and diet on canine cerebral cortex transcription. Neurobiol Aging 30:1314-1326
32. Wang L, Giannoudis A, Lane S, Williamson P, Pirmohamed M, Clark RE (2008) Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia. Clin Pharmacol Ther 83:258-264
33. Ciarimboli G, Deuster D, Knief A, Sperling M, Holtkamp M, Edemir B, Pavenstadt H, Lanvers-Kaminsky C, Am Zehnhoff-Dinnesen A, Schinkel AH, Koepsell H, Jurgens H, Schlatter E (2010) Organic cation transporter 2 mediates cisplatin-induced oto-and nephrotoxicity and is a target for protective interventions. Am J Pathol 176:1169-1180
34. Ma Y, Yuan RQ, Fan S, Hu C, Goldberg ID, Laterra JJ, Rosen EM (2006) Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum. Anticancer Drugs 17:733-751 (Pubitemid 44310171)
35. McLean LA, Gathmann I, Capdeville R, Polymeropoulos MH, Dressman M (2004) Pharmacogenomic analysis of cytogenetic response in chronic myeloid leukemia patients treated with imatinib. Clin Cancer Res 10:155-165 (Pubitemid 38114174)
36. White DL, Saunders VA, Dang P, Engler J, Zannettino AC, Cambareri AC, Quinn SR, Manley PW, Hughes TP (2006) OCT-1-mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib. Blood 108:697-704 (Pubitemid 44061372)
37. Thomas J, Wang L, Clark RE, Pirmohamed M (2004) Active transport of imatinib into and out of cells: implications for drug resistance. Blood 104:3739-3745 (Pubitemid 39564452)
38. Grefen C, Lalonde S, Obrdlik P (2007) Split-ubiquitin system for identifying protein-protein interactions in membrane and fulllength proteins. Curr Protoc Neurosci 41:5.27.1-5.27.41
39. Xia Z, Liu Y (2001) Reliable and global measurement of fluorescence resonance energy transfer using fluorescence microscopes. Biophys J 81:2395-2402 (Pubitemid 32917186)
40. Sorkin A, McClure M, Huang F, Carter R (2000) Interaction of EGF receptor and grb2 in living cells visualized by fluorescence resonance energy transfer (FRET) microscopy. Curr Biol 10:1395-1398
41. Feige JN, Sage D, Wahli W, Desvergne B, Gelman L (2005) PixFRET, an imageJ plug-in for FRET calculation that can accommodate variations in spectral bleed-throughs. Microsc Res Tech 68:51-58 (Pubitemid 41464009)
42. Sitte HH, Farhan H, Javitch JA (2004) Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking. Mol Interv 4:38-47 (Pubitemid 38702123)
43. Pietig G, Mehrens T, Hirsch JR, Cetinkaya I, Piechota H, Schlatter E (2001) Properties and regulation of organic cation transport in freshly isolated human proximal tubules. J Biol Chem 276:33741-33746
44. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C (T)] method. Methods 25:402-408 (Pubitemid 34164012)